SEVERE COMBINED IMMUNODEFICIENCY
Clinical trials for SEVERE COMBINED IMMUNODEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new SEVERE COMBINED IMMUNODEFICIENCY trials appear
Sign up with your email to follow new studies for SEVERE COMBINED IMMUNODEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New gene therapy offers hope for babies born without an immune system
Disease control Recruiting nowThis study is testing a new gene therapy for children with Artemis-SCID, a rare and life-threatening disorder where babies are born without a working immune system. Doctors take a child's own blood stem cells, use a modified virus to insert a healthy copy of the missing gene, and…
Matched conditions: SEVERE COMBINED IMMUNODEFICIENCY
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Apr 03, 2026 23:05 UTC
-
New hope for kids with rare immune diseases: special stem cell process opens up
Disease control AVAILABLEThis program provides expanded access to a special method of preparing stem cells for transplant. It is designed for patients with severe immune deficiencies, sickle cell disease, and other conditions where a standard transplant carries high risks. The process aims to reduce a da…
Matched conditions: SEVERE COMBINED IMMUNODEFICIENCY
Sponsor: University of Florida • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Scientists hunt genetic clues to rare immune disorder
Knowledge-focused Recruiting nowThis study aims to discover the genetic causes of severe combined immunodeficiency (SCID), a rare condition where the immune system doesn't work properly. Researchers will analyze blood samples from 100 participants, including patients with SCID and their relatives, to identify s…
Matched conditions: SEVERE COMBINED IMMUNODEFICIENCY
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:47 UTC